Three neuromodulation therapies have been appropriately tested and approved in refractory
focal epilepsies: vagus nerve stimulation (VNS), deep brain stimulation of the anterior …

Transient electronic systems represent an emerging class of technology that is defined by an
ability to fully or partially dissolve, disintegrate, or otherwise disappear at controlled rates or …

Bioresorbable silicon electronics technology offers unprecedented opportunities to deploy
advanced implantable monitoring systems that eliminate risks, cost and discomfort …

Inaccurate subjective seizure counting poses treatment and diagnostic challenges and thus
suboptimal quality in epilepsy management. The limitations of existing hospital‐and home …

Objective Evaluate the seizure‐reduction response and safety of mesial temporal lobe (MTL)
brain‐responsive stimulation in adults with medically intractable partial‐onset seizures of …

Despite the development of new antiepileptic drugs (AEDs),~ 20%–30% of people with
epilepsy remain refractory to treatment and are said to have drug-resistant epilepsy (DRE) …

Electroencephalography (EEG) remains an essential diagnostic tool for people with epilepsy
(PWE). The International Federation of Clinical Neurophysiology produces new guidelines …

Controlled clinical trials in adults with medically intractable focal seizures treated with the
RNS® System demonstrate that closed-loop responsive neurostimulation to the seizure …

Neuromodulation is a key therapeutic tool for clinicians managing patients with drug‐
resistant epilepsy. Multiple devices are available with long‐term follow‐up and real‐world …

Planning surgery for patients with medically refractory epilepsy often requires recording
seizures using intracranial EEG. Quantitative measures derived from interictal intracranial …